// App-Quantinova.ai

TCT-254 : Everolimus Eluting Bioresorbable Vascular Scaffolds In Patients With ST-Segment Myocardial Infarction. Safety Feasibility and Acute Performance

Researchers

Presenter

  • Roberto Diletti

Principal Investigators

  • Antonios Karanasos

  • Takashi Muramatsu

  • Shimpei Nakatani

  • Sjoerd T. Nauta

  • Yoshinobu Onuma

  • Evelyn Regar

  • Carl J. Schultz

  • Patrick W. Serruys

  • Robert J. Van Geuns

Medical Centers

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • Thoraxcenter, Rotterdam, The Netherlands, Rotterdam, Netherlands

  • Sakurabashi Watanabe Hospital, Osaka, Japan

  • Erasmus MC, Rotterdam, Netherlands

  • Thoraxcenter, Rotterdam, Netherlands

Locations

  • Japan

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved